Nordixate® Methotrexate Pre-filled Syringe approved in Colombia

News

Nordixate® Methotrexate Pre-filled Syringe approved in Colombia

Nordixate® Methotrexate Pre-filled Syringe approved in Colombia
septiembre 21, 2021 marpalop
nordic-pharma-espana-nordic-pharma-en-el-mundo
Date
Category Corporativo Nordic Phama

Nordic Pharma AAP is pleased to announce that the Nordixate® Methotrexate Pre-filled Syringe has been issued market authorization by Instituto Nacional de Vigilancia de Medicamentos y Alimentos, or INVIMA, the Colombian National Food and Drug Surveillance Institute.

With our local partner, Vitalis Laboratorio, we are working towards a launch early next year.

Thank you to everyone who has been involved in achieving this approval.

nordic-pharma-vitalis-expertos-en-inyectables